Cargando…
Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure
Primary breast diffuse large B‐cell lymphoma (PB‐DLBCL) is a rare subtype of DLBCL with limited data on patterns of failure. This multicenter study aimed to define the optimum treatment strategy and patterns of failure for PB‐DLBCL patients. We retrospectively reviewed data on 108 PB‐DLBCL patients...
Autores principales: | Hu, Shaoxuan, Song, Yuqin, Sun, Xiuhua, Su, Liping, Zhang, Wei, Jia, Jing, Bai, Ou, Yang, Sheng, Liang, Rong, Li, Xiaoling, Zhang, Huilai, Gao, Yuhuan, Zhang, Weijing, Xiao, Xiubin, Bao, Huizheng, Wang, Ningju, Ren, Hanyun, Cen, Xinan, Yang, Shun'e, Zhao, Yu, Wang, Yinan, Wang, Yalan, Liu, Aichun, Wang, Jingwen, Shi, Yuankai, Yuan, Ming, Li, Yufu, He, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272095/ https://www.ncbi.nlm.nih.gov/pubmed/30302857 http://dx.doi.org/10.1111/cas.13828 |
Ejemplares similares
-
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
por: Zhong, Kaili, et al.
Publicado: (2023) -
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
por: Zhang, Wei, et al.
Publicado: (2021) -
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
por: Yang, Haiyan, et al.
Publicado: (2022) -
PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity
por: Zheng, Wen, et al.
Publicado: (2018) -
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
por: Shi, Yuankai, et al.
Publicado: (2020)